Most cases of never-smokers’ lung cancer treatable with mutation-targeting drugs: Available, FDA-approved drugs may be effective in targeting about 80% of never-smokers’ lung tumors
Despite smoking’s well-known role in causing lung cancer, a significant number of patients who develop lung tumors have never smoked. While scientists are still working to understand what spurs cancer in so-called “never-smokers,” a study led by scientists at Washington University School of Medicine in St. Louis demonstrates new possibilities for treating these baffling tumors. […]